Results 31 to 40 of about 37,917 (298)

Dual Antiplatelet Therapy for Heart Disease [PDF]

Circulation, 2014
Within the body, the heart pumps blood through paths called vessels so that all of the body’s organs get the oxygen and nutrients they need to function properly. The blood itself contains many components in addition to oxygen and nutrients, including tiny plate-shaped cell fragments fittingly called platelets.
Edward T, Carreras, Jessica L, Mega
openaire   +2 more sources

Single versus dual antiplatelet therapy following peripheral arterial endovascular intervention for chronic limb threatening ischaemia: Retrospective cohort study.

PLoS ONE, 2020
ObjectivesAntiplatelet therapy following peripheral arterial endovascular intervention lacks high quality evidence to guide practice. The aim of this study was to assess the effect of three months of dual antiplatelet therapy on amputation-free survival ...
Natasha Chinai, Graeme K Ambler, Bethany G Wardle, Dafydd Locker, Dave Bosanquet, Nimit Goyal, Christopher Chick, Robert J Hinchliffe, Christopher P Twine   +8 more
doaj   +1 more source

Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis

BMC Neurology, 2020
Background New evidence on the efficacy and safety of dual antiplatelet therapy for secondary stroke prevention have been realized in the recent years. An updated meta analysis was done to determine the effect of the various dual antiplatelets vs aspirin
Christessa Emille Que Albay, Frederick Gavril D. Leyson, Federick C. Cheng   +2 more
doaj   +1 more source

From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease

Journal of Investigative Medicine High Impact Case Reports, 2021
Drug-eluting stents (DES) have superior efficacy compared with bare metal stents (BMS) for treatment of coronary artery lesions. However, BMS continue to play an important role in percutaneous coronary intervention for patients who are at a high bleeding
Taylor C. Remillard MD, Don C. Rockey MD
doaj   +1 more source

Personalized Antiplatelet Therapy Following Endovascular Revascularization in Peripheral Artery Occlusive Disease: A Novel Concept

EJVES Short Reports, 2015
: Case: A 73 year old patient with a longstanding history of peripheral artery occlusive disease (PAOD) presented with an acute on chronic progression of symptoms, based on a long occlusion of the superficial femoral artery (SFA), which was treated by ...
S.M.O. Peeters Weem, T.C. Leunissen, M. Teraa, E.J. Vonken, G.J. de Borst, F.L. Moll   +5 more
doaj   +1 more source

Evaluation of race and ethnicity disparities in outcome studies of CYP2C19 genotype-guided antiplatelet therapy

Frontiers in Cardiovascular Medicine, 2022
Dual antiplatelet therapy with a P2Y12 inhibitor (clopidogrel, prasugrel, or ticagrelor) and aspirin remains the standard of care for all patients undergoing percutaneous coronary intervention (PCI).
Anh B. Nguyen, Larisa H. Cavallari, Joseph S. Rossi, George A. Stouffer, Craig R. Lee, Craig R. Lee   +5 more
doaj   +1 more source

Subgroup based on single antiplatelet therapy (SAPT) choice following dual antiplatelet therapy (DAPT) in the short DAPT arm.

, 2023
Subgroup based on single antiplatelet therapy (SAPT) choice following dual antiplatelet therapy (DAPT) in the short DAPT arm.
Kevin R. Bainey (11060747), Andrew Yan (2422876), Blair J. MacDonald (16920547), David Bewick (16920550), Ricky D. Turgeon (6411179), Guillaume Marquis-Gravel (4044482)   +5 more
core   +1 more source

The CLEAR (Considering Leading Experts’ Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention

CVIR Endovascular, 2019
Background Antiplatelet and anticoagulant therapy are commonly used before, during and after peripheral arterial endovascular intervention. This survey aimed to establish antiplatelet and anticoagulant choice for peripheral arterial endovascular ...
Kitty H. F. Wong, Dave C. Bosanquet, Graeme K. Ambler, Mahim I. Qureshi, Robert J. Hinchliffe, Christopher P. Twine, CLEAR survey collaborators   +6 more
doaj   +1 more source

Antithrombotic therapy after angioplasty of pulmonary vein stenosis due to atrial fibrillation ablation: A two‐center experience and review of the literature

Journal of Arrhythmia, 2022
Background Pulmonary vein stenosis (PVS) is a severe complication of atrial fibrillation (AF) ablation resulting in narrowing of affected pulmonary veins (PVs). Interventional treatment consists of angioplasty with or without PV stenting.
Thomas Fink, Julia Vogler, Riccardo Proietti, Vanessa Sciacca, Christian‐Hendrik Heeger, Laura Rottner, Tilman Maurer, Andreas Metzner, Shibu Mathew, Charlotte Eitel, Ingo Eitel, Christian Sohns, Makoto Sano, Bruno Reissmann, Andreas Rillig, Feifan Ouyang, Karl‐Heinz Kuck, Roland Richard Tilz   +17 more
doaj   +1 more source

Dual Antiplatelet Therapy De-escalation Strategies [PDF]

The American Journal of Cardiology, 2021
Dual antiplatelet therapy (DAPT), the combination of aspirin (ASA), and a P2Y12 inhibitor, protects against stent thrombosis and new atherothrombotic events after a stent implantation or an acute coronary syndrome, but exposes patients to an increased risk of bleeding.
Peter R, Sinnaeve, Tom, Adriaenssens
openaire   +2 more sources